Seebri Neohaler Interactions
There are 203 drugs known to interact with Seebri Neohaler (glycopyrrolate), along with 15 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 5 are major, 181 are moderate, and 17 are minor.
- View all 203 medications that may interact with Seebri Neohaler
- View Seebri Neohaler alcohol/food interactions (2)
- View Seebri Neohaler disease interactions (15)
Most frequently checked interactions
View interaction reports for Seebri Neohaler (glycopyrrolate) and the medicines listed below.
- acrivastine
- acrivastine
- Advair HFA (fluticasone / salmeterol)
- Advair HFA (fluticasone / salmeterol)
- albuterol
- albuterol
- allopurinol
- allopurinol
- amlodipine
- amlodipine
- aspirin
- aspirin
- atorvastatin
- atorvastatin
- Breo Ellipta (fluticasone / vilanterol)
- Breo Ellipta (fluticasone / vilanterol)
- carbocysteine
- carbocysteine
- colchicine
- colchicine
- lansoprazole
- lansoprazole
- montelukast
- montelukast
- Symbicort (budesonide / formoterol)
- Symbicort (budesonide / formoterol)
- Ventolin (albuterol)
- Ventolin (albuterol)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Seebri Neohaler alcohol/food interactions
There are 2 alcohol/food interactions with Seebri Neohaler (glycopyrrolate).
Seebri Neohaler disease interactions
There are 15 disease interactions with Seebri Neohaler (glycopyrrolate) which include:
- arrhythmias
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- tardive dyskinesia
- infectious diarrhea
- myasthenia gravis
- ulcerative colitis
- psychoses
- Down's syndrome
- liver impairment
- renal impairment
- hypertension
- fever
Report options
More about Seebri Neohaler (glycopyrrolate)
- Seebri Neohaler consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro Ellipta
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Stiolto Respimat
Stiolto Respimat (tiotropium bromide and olodaterol) is used to treat COPD. Includes Stiolto ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.